CHANGE IN RATINGS
Abercrombie & Fitch (FBR Quote) upgraded at FBR to Outperform from Market Perform based on a change in promotional philosophy and a positive effect on recent clearance sales. Price target increased to $37 from $21. CB Richard Ellis (CBRE Quote) upgraded at Goldman Sachs to Neutral from Sell based on valuation. Expect transaction activity to remain low and note constrained capital resources. See potential for earnings recovery but prefer JLL based on more appropriate leverage ratios as well as segment and geographic diversity. Price target at $7. Coventry Health Care (CVH Quote) downgraded at UBS to Neutral from Buy. Links to macroeconomic factors and stretched valuation has led to the decrease in ratings. Maintains target price of $19.
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,469.76 | 1,108.79 | 2,176.70 | 32.42 |
Oil *
79.67
|
|
UP
124.92
|
UP
13.16
|
UP
32.10
|
UP
0.41
|
10 Yr
3.24%
SPDR Gold
117.50
|
|
+1.21%
|
+1.20%
|
+1.50%
|
+1.28%
|
Data delayed 20 minutes |














